Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.

Source:http://linkedlifedata.com/resource/pubmed/id/11802211

Int. J. Cancer 2002 Feb 1 97 4 489-92

Download in:

View as

General Info

PMID
11802211